MAPT and Cognitive impairment: Consistent with this, aggregation of nonphosphorylated tau correlates with the onset and extent of cognitive impairment in mice (21) and humans (74, 75), whereas phospho-tau pathology appears to be a late stage event in the disease progression (74).